Latest News
Stay up to date on the latest scientific news
What is PrenatalSAFE® test ?
PrenatalSAFE® is a non-invasive prenatal test that, analyzing circulating cell-free fetal DNA isolated from a sample of maternal blood, and includes 8 levels of depth thanks to which is possible to achieve the most complete pregnancy informational framework available today. In fact, the test allows seeing aneuploidies and microdeletion syndromes, from the most common to the rarest, structural abnormalities in all fetus chromosomes and the presence of mutations related to severe genetic disorders.
Useful forms
Brochures
A simple blood sample (8-10 ml) collected at 10^ weeks of gestation is required, from which the circulating cell-free fetal DNA is analyzed.
It is a non-invasive test, therefore the risks of abortion present in traditional invasive prenatal diagnosis techniques, such as amniocentesis and CVS, are eliminated. No risk for the fetus and the mother.
Thanks to the new high resolution FAST Technology, PrenatalSAFE turnaround time is just of 3 working days.
99,9% sensibility for chromosomes 21, 18, 13, and sex chromosomes aneuploidies with a percentage of false positives lower than 0.01 (
Fiorentino et Al., 2016)
It allows detecting chromosome aneuploidies even at small quantities of fetal DNA (2%), unlike other tests that require a quantity of fetal DNA > 4%..
PrenatalSAFE® is the non-invasive prenatal test that provides the clearest results: aneuploidy DETECTED or NO aneuploidy DETECTED, within the limits of the resolution of the method.